BioForm Medical, Inc. Release: FDA Advisory Panel Meeting To Evaluate Radiesse(R), A Next-Generation, Long-Lasting Product For Soft Tissue Augmentation In Two Facial Aesthetic Applications

SAN MATEO, Calif., Aug. 23 /PRNewswire/ -- The U.S. Food and Drug Administration's (FDA) General and Plastic Surgery Devices Advisory Panel will discuss and make recommendations on a premarket approval application (PMA) for Radiesse to be used as an injectable device intended for use in the correction of facial lipoatrophy associated with HIV therapy and a second PMA for the same device intended for use as a filler material to restore soft tissue facial contours such as nasolabial folds.